U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Osteoporosis Disease Liaison

Field SalesConfirmed live in the last 24 hours
Full-timeJapanNo salary listed

About the Job

Requirements

  • A Bachelor's degree, preferably science-based.
  • Key account experience.
  • MR certification is required, along with the ability to conduct clinical and scientific discussions.
  • Build and maintain expert-level knowledge of the therapeutic area, including drug treatments such as EVENITY and competitor products, standard care under the 2025 JOS guidelines, and clinical treatment approaches.
  • High communication, negotiation, and project management skills, including experience collaborating with regional medical societies to establish and expand optimal standards of care in target accounts or regions.
  • Analytical skills and experience evaluating account opportunities and performance and developing account-specific strategies.
  • Collaboration skills and experience working closely with internal stakeholders at Astellas and Amgen, including medical representatives, sales managers, and the bone ecosystem strategy manager.

Responsibilities

  • Adopt a key account approach to translate national osteoporosis guidelines into actionable treatment algorithms in each region.
  • Work directly with physicians and other regional healthcare stakeholders, including Osteoporosis Liaison Service Managers, to establish the Bone Care Pathway in routine clinical workflows through appropriate identification of very-high-fracture-risk patients, cross-departmental collaboration, and effective project support.
  • Develop inpatient and outpatient Bone Care Pathway models that include guideline-based treatment protocols and appropriately position bone-building therapies and EVENITY.
  • Coordinate closely with medical representatives in AKK/API, sales managers, and the API-CSC team to ensure consistent customer follow-up and engagement. Work closely with the Amgen Bone Ecosystem Strategy Manager on account targeting and activities to align with Amgen brand plans.
  • Communicate the value of EVENITY in the context of JOS guidelines, explaining the benefits of a bone-builder-first approach for patients at very high fracture risk and EVENITY's differentiation within that approach.
  • Support and use tools and seminars effectively with the ecosystem team to demonstrate the value of structured post-fracture care and risk-stratified treatment and guide implementation.
  • If EVENITY has not been adopted for inpatient or outpatient use, UCB does not participate in adoption activities; Amgen or Astellas, the marketing company, conducts them.

Desired Qualifications

  • Experience planning and implementing disease-area initiatives is desirable, particularly experience in osteoporosis.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs